Citations 1
A phase I study to evaluate safety, tolerability, pharmacokinetics and activity of oraxol in patients (pts) with advanced malignancies.
Azad, Nilofer S. , Dy, Grace K. , Gallagher, Denise , Brennen, Caden, Cutler, David L. , Kramer, Douglas, Kwan, Rudolf, Fetterly, Gerald J., Adjei, Alex A. , Jimeno, Antonio , Wee, Wen , Lam, Elaine T. , Diamond, Jennifer R. , Opyrchal, Mateusz , Chan, WingâKai
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 2526-2526
